Total Payments
$142,471
2024 Payments
$22,174
Companies
60
Transactions
890
Medicare Patients
3,121
Medicare Billing
$380,210
Payment Breakdown by Category
Other$97,595 (68.5%)
Food & Beverage$23,125 (16.2%)
Consulting$10,688 (7.5%)
Travel$6,737 (4.7%)
Research$4,250 (3.0%)
Education$75.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,595 | 59 | 68.5% |
| Food and Beverage | $23,125 | 810 | 16.2% |
| Consulting Fee | $10,688 | 3 | 7.5% |
| Travel and Lodging | $6,737 | 11 | 4.7% |
| Unspecified | $4,250 | 2 | 3.0% |
| Education | $75.93 | 5 | 0.1% |
Payments by Type
General
$138,221
888 transactions
Research
$4,250
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $76,893 | 287 | $0 (2024) |
| Allergan Inc. | $27,034 | 94 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $8,636 | 13 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $8,119 | 9 | $0 (2019) |
| UCB Biosciences Inc. | $4,250 | 2 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $3,205 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $1,130 | 76 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,071 | 9 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,051 | 62 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $974.12 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,174 | 143 | ABBVIE INC. ($10,685) |
| 2023 | $19,254 | 126 | ABBVIE INC. ($17,092) |
| 2022 | $21,513 | 70 | ABBVIE INC. ($20,274) |
| 2021 | $9,475 | 97 | AbbVie Inc. ($5,298) |
| 2020 | $7,260 | 52 | UCB Biosciences Inc. ($4,250) |
| 2019 | $24,713 | 156 | Endo Pharmaceuticals Inc. ($8,119) |
| 2018 | $11,310 | 111 | AbbVie, Inc. ($5,519) |
| 2017 | $26,770 | 135 | Allergan Inc. ($15,710) |
All Payment Transactions
890 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $18.22 | General |
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $100.97 | General |
| Category: Urology | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $1,129.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $48.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $120.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $19.69 | General |
| 12/04/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Urology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), RELTONE 400 MG, GLYCATE | Food and Beverage | In-kind items and services | $131.37 | General |
| Category: GALLSTONES | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: GI | ||||||
| 11/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $128.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Hepatology / Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol CIMZIA For Crohn's Disease | UCB Biosciences Inc. | $4,250 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 697 | 786 | $647,473 | $83,402 |
| 2022 | 14 | 776 | 953 | $693,358 | $98,770 |
| 2021 | 17 | 911 | 1,093 | $723,935 | $113,635 |
| 2020 | 16 | 737 | 863 | $602,821 | $84,403 |
Total Patients
3,121
Total Services
3,695
Medicare Billing
$380,210
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 72 | 74 | $105,524 | $15,335 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 186 | $44,082 | $11,829 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 128 | $44,544 | $11,411 | 25.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 58 | 60 | $65,608 | $10,649 | 16.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 127 | 134 | $156,328 | $9,382 | 6.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 87 | 88 | $131,529 | $8,470 | 6.4% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 15 | 27 | $24,381 | $5,896 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $15,176 | $3,476 | 22.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 21 | 21 | $25,621 | $2,532 | 9.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $13,050 | $2,200 | 16.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $19,500 | $1,719 | 8.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $2,130 | $504.28 | 23.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 101 | 102 | $145,452 | $19,631 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 259 | $61,383 | $16,443 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 144 | $50,112 | $12,781 | 25.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 130 | $145,924 | $9,352 | 6.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 50 | 50 | $52,900 | $9,336 | 17.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 18 | 40 | $36,120 | $8,686 | 24.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 62 | 64 | $85,952 | $6,111 | 7.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 11 | 37 | $37,000 | $3,905 | 10.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $16,110 | $3,281 | 20.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $21,260 | $2,914 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $10,840 | $2,157 | 19.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $11,693 | $2,062 | 17.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 14 | 14 | $16,198 | $1,468 | 9.1% |
About Dr. Kenneth Feuer, MD
Dr. Kenneth Feuer, MD is a Gastroenterology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902872781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Feuer, MD has received a total of $142,471 in payments from pharmaceutical and medical device companies, with $22,174 received in 2024. These payments were reported across 890 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,595).
As a Medicare-enrolled provider, Feuer has provided services to 3,121 Medicare beneficiaries, totaling 3,695 services with total Medicare billing of $380,210. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Orlando, FL
- Active Since 02/23/2006
- Last Updated 10/21/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1902872781
Products in Payments
- LINZESS (Drug) $39,988
- SKYRIZI (Biological) $19,182
- Humira (Biological) $10,983
- VOQUEZNA (Drug) $8,636
- NASCOBAL (Drug) $8,119
- HUMIRA (Biological) $4,617
- Cimzia (Drug) $4,479
- RINVOQ (Biological) $3,490
- VIBERZI (Drug) $2,587
- STELARA (Biological) $1,922
- Mulpleta (Drug) $919.61
- RELTONE 200 MG (Drug) $857.54
- SPYGLASS (Device) $637.68
- CREON (Drug) $625.42
- Axonics (Device) $569.76
- ZENPEP (Drug) $552.53
- XELJANZ (Drug) $548.48
- ENTYVIO (Biological) $495.62
- DUPIXENT (Biological) $479.11
- XIFAXAN (Drug) $427.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Orlando
Dr. Samuel Giday, M.d, M.D
Gastroenterology — Payments: $2.6M
Gastroenterology $2.6M
Jennifer Seminerio-Diehl, Md, MD
Gastroenterology — Payments: $814,283
Gastroenterology $814,283
Dr. Robert Hawes, Md, MD
Gastroenterology — Payments: $593,475
Gastroenterology $593,475
Muhammad Hasan, Md, MD
Gastroenterology — Payments: $261,176
Gastroenterology $261,176
Dr. Natalie Cosgrove, Md, MD
Gastroenterology — Payments: $132,710
Gastroenterology $132,710
Dr. Patrick Basu, M.d, M.D
Gastroenterology — Payments: $117,734
Gastroenterology $117,734